US2010041687A1PendingUtilityA1
Hydrobromide salt of an anti-hiv compound
Assignee: THONE DANIEL JOSEPH CHRISTIAANPriority: Dec 6, 2006Filed: Dec 6, 2007Published: Feb 18, 2010
Est. expiryDec 6, 2026(~0.4 yrs left)· nominal 20-yr term from priority
Inventors:Daniel Joseph Christiaan Thone
A61K 9/145A61K 9/1641A61P 31/18A61K 9/1635A61K 9/1652
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Solid dispersions and dosage forms comprising the hydrobromide salt of a diarylpyrimidine derivative, useful as an anti-HIV agent.
Claims
exact text as granted — not AI-modified1 . A solid dispersion comprising a compound of formula (I):
in a water-soluble polymer.
2 . The solid dispersion of claim 1 , wherein the water-soluble polymer is selected from hydroxypropylmethyl cellulose, polyvinyl pyrrolidone, copolyvidone, and vitamin E TGPS.
3 . The solid dispersion of claim 4 , wherein the polymer is hydroxypropylmethyl cellulose 2910 5 cps
4 . The solid dispersion of claim 3 , wherein the ratio of the polymer to pharmaceutical agent is in the range from 9:1 to 1:1.
5 . The solid dispersion of claim 6 , wherein the ratio of polymer to pharmaceutical agent is in the range from 3:1 to 1:1.
6 . A dosage form comprising the compound of claim 1 or claim 2 or the solid dispersion of claim 3 .
7 . The dosage form of claim 9 , wherein the dosage form is selected from a tablet or a capsule.
8 . A compound of formula (I):
9 . The compound of claim 1 having a degree of crystallinity of about 10% or less, or of about 5% or less, or of about 1% or less.
10 . A pharmaceutical composition comprising a compound of formula (I) as defined in claim 8 and a carrier.Join the waitlist — get patent alerts
Track US2010041687A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.